Increased expression of transforming growth factor-β1 as a stabilizing factor in human atherosclerotic plaques

Stroke

Volumn 35, Issue 10, 2004, Pages 2253-2257

  Cipollone, Francesco ^a,b   Fazia, Maria ^a   Mincione, Gabriella ^a   Iezzi, Annalisa ^a   Pini, Barbara ^a   Cuccurullo, Chiara ^a   Ucchino, Sante ^a   Spigonardo, Francesco ^a   Di Nisio, Marcello ^a   Cuccurullo, Franco ^a   Mezzetti, Andrea ^a   Porreca, Ettore ^a  

^a Aging Research Center   (Italy)

^b Ctr Regionale Per Prev dell'A   (Italy)

Author keywords

Atherosclerosis; Carotid stenosis; Growth factors; Inflammation

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN; COLLAGEN; DYE; HLA DR ANTIGEN; MESSENGER RNA; PROCOLLAGEN; SIRIUS RED; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STROKE; SYMPTOM; T LYMPHOCYTE SUBPOPULATION; TRANSIENT ISCHEMIC ATTACK; WESTERN BLOTTING;

AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ARTERIOSCLEROSIS; CAROTID STENOSIS; COLLAGEN TYPE I; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MYOCYTES, SMOOTH MUSCLE; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4744371004     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000140739.45472.9c     Document Type: Article

References (13)

1. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
2. Cipollone F, Fazia M, Iezzi A, Zucchelli M, Pini B, De Cesare D, Ucchino S, Spigonardo F, Bajocchi G, Bei R, Muraro R, Artese L, Piattelli A, Chiarelli F, Cuccurullo F, Mezzetti A. Suppression of the functionally coupled cyclooxygenase-2/PGE synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation. 2003;107:1479-1485.
3. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor-beta in human disease. N Engl J Med. 2000;342:1350-1358.
4. Tedgui A, Mallat Z. Antiinflammatory mechanisms in the vascular wall. Circ Res. 2001;88:877-887.
5. Bobik A, Agroti A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, Tararak E, Condron M, Kostolias G. Distinct patterns of transforming growth factor-β isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-β in fibrofatty lesion development. Circulation. 1999;99:2883-2891.
6. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R, Fradelizi D, Tedgui A. Inhibition of transforming growth factor-β signalling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res. 2001;89:930-934.
7. Lutgens E, Gijbels M, Smook M, P, Gotwals P, Koteliansky VE, Daemen MJ. Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol. 2002;22:975-982.
8. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445-453.
9. Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R, Chiarelli F, Schmidt AM, Cuccurullo F, Mezzetti A. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation. 2003;108:1070-1077.
10. Porreca E, Di Febbo C, Baccante G, Di Nisio M, Cuccurullo F. Increased transforming growth factor-beta1 circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin. J Am Coll Cardiol. 2002;39:1752-1757.
11. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med. 1994;330:1431-1438.
12. McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanborn TA, Spokojny AM, Bush HL Jr. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-β1. J Clin Invest. 1995;96:2667-2675.
13. Lutgens E, Cleutjens KB, Heeneman S, Koteliansky VE, Burkly LC, Daemen MJ. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci USA. 2000;97:7464-7469.